Henry A. Feldman — Endo Lab

article 2016

The Effects of Gonadotropin-Releasing Hormone Agonist Combined with Add-Back Therapy on Quality of Life for Adolescents with Endometriosis: A Randomized Controlled Trial

Journal of Pediatric and Adolescent Gynecology ·doi:10.1016/j.jpag.2016.02.008

Study objectiveUse of gonadotropin-releasing hormone agonists (GnRHa) to treat endometriosis can cause mood and vasomotor side effects. "Add-back therapy," the combination of low-dose hormones, limits side effects but research is limited to…

article 2015

45. The Effect of Hormonal Add-back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial

·doi:10.1016/j.jadohealth.2014.10.049

article 2015

Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis

Obstetrics and gynecology ·doi:10.1097/aog.0000000000000964

OBJECTIVE: To assess whether add-back therapy with norethindrone acetate or norethindrone acetate plus conjugated equine estrogens is superior to maintain bone health in adolescents and young women using gonadotropin-releasing hormone agoni…

article 2015

Hormonal Add-Back Therapy for Females Treated With Gonadotropin-Releasing Hormone Agonist for Endometriosis

·doi:10.1097/ogx.0000000000000249

Endometriosis often begins during adolescence. Appropriate management includes prompt initiation of therapy and long-term maintenance therapy. Gonadotropin-releasing hormone (GnRH) agonists are commonly used second-line therapy for patients…

article 2015

The Effect of Hormonal Add-Back Therapy in Adolescents Treated With a Gonadotropin Releasing Hormone (GnRH) Agonist for Endometriosis: A Randomized Trial

·doi:10.1016/j.jpag.2015.02.008